학술논문

Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial
Document Type
article
Source
Open Heart. 8(2)
Subject
Heart Disease
Clinical Trials and Supportive Activities
Cardiovascular
Clinical Research
Heart Disease - Coronary Heart Disease
6.1 Pharmaceuticals
Evaluation of treatments and therapeutic interventions
Female
Follow-Up Studies
Humans
Magnetic Resonance Imaging
Cine
Male
Middle Aged
Myocardial Infarction
Myocardium
Myocytes
Cardiac
Retrospective Studies
Stem Cell Transplantation
Stroke Volume
Transplantation
Autologous
Ventricular Dysfunction
Left
Ventricular Function
Left
MRI
coronary artery disease
epidemiology
Language
Abstract
Most cell therapy trials failed to show an improvement in global left ventricular (LV) function measures after myocardial infarction (MI). Myocardial segments are heterogeneously impacted by MI. Global LV function indices are not able to detect the small treatment effects on segmental myocardial function which may have prognostic implications for cardiac events. We aimed to test the efficacy of allogeneic cardiosphere-derived cells (CDCs) for improving regional myocardial function and contractility. In this exploratory analysis of a randomised clinical trial, 142 patients with post-MI with LVEF